A carregar...

Tβ4–Ac-SDKP pathway: Any relevance for the cardiovascular system?

The last 20 years witnessed the emergence of the thymosin β4 (Tβ4)–N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) pathway as a new source of future therapeutic tools to treat cardiovascular and renal diseases. In this review article, we attempted to shed light on the numerous experimental findings...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Physiol Pharmacol
Main Authors: Kassem, Kamal M., Vaid, Sonal, Peng, Hongmei, Sarkar, Sarah, Rhaleb, Nour-Eddine
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6824425/
https://ncbi.nlm.nih.gov/pubmed/30854877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1139/cjpp-2018-0570
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!